tiprankstipranks
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
16,948 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -1.58, suggesting Moderna is a Buy.
Moderna’s (MRNA) 20-Day exponential moving average is 34.18, while Moderna’s (MRNA) share price is $30.96, making it a Sell.
Moderna’s (MRNA) 50-Day exponential moving average is 37.78, while Moderna’s (MRNA) share price is $30.96, making it a Sell.

Moderna (MRNA) Pivot Points

Mar 03, 2025, 08:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
28.39
29.70
30.39
31.70
32.39
33.70
34.39
Fibonacci
29.70
30.46
30.93
31.70
32.46
32.93
33.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Mar 03, 2025, 08:45 AM
Period
Simple
Exponential
MA5
32.56Sell
32.28Sell
MA10
33.67Sell
33.03Sell
MA20
33.66Sell
34.18Sell
MA50
37.46Sell
37.78Sell
MA100
43.02Sell
46.67Sell
MA200
75.24Sell
70.97Sell
Moderna’s (MRNA) 10-Day exponential moving average is 33.03, while Moderna’s (MRNA) share price is $30.96, making it a Sell.
Moderna’s (MRNA) 100-Day exponential moving average is 46.67, while Moderna’s (MRNA) share price is $30.96, making it a Sell.
Moderna’s (MRNA) stock price is $30.96 and Moderna’s (MRNA) 50-day simple moving average is 37.46, creating a Sell signal.
Moderna’s (MRNA) stock price is $30.96 and Moderna’s (MRNA) 100-day simple moving average is 43.02, creating a Sell signal.
Moderna’s (MRNA) stock price is $30.96 and Moderna’s (MRNA) 200-day simple moving average is 75.24, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Mar 03, 2025, 08:45 AM
Name
Value
Implied Action
RSI (14)
38.84
Neutral
STOCH (9,6)
30.34
Neutral
STOCHRSI (14)
33.98
Neutral
MACD (12,26)
-1.58
Buy
ADX (14)
11.86
Buy
Williams %R
-77.88
Buy
CCI (14)
-113.35
Buy
ATR (14)
2.59
-
Ultimate Oscillator
41.51
Neutral
ROC
-5.03
Sell
Moderna’s (MRNA) Relative Strength Index (RSI) is 38.84, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 11.86, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is -113.35, creating a Buy signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is -5.03, creating a Sell signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Sell.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 38.84, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is -1.58, which suggests MRNA is a Buy.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 32.56, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 33.66, which suggests MRNA is a Sell.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 37.46, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 75.24, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -77.88, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is -113.35, which suggests MRNA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis